Evidence map›Paper›PMID 24348336›Full record

ArticleFrontiers in cellular neuroscience2013

A role for the canonical nuclear factor-κB pathway in coupling neurotrophin-induced differential survival of developing spiral ganglion neurons.

Renaud Vandenbosch, Eva Chocholova, Pierre A Robe, Yiqiao Wang, Cécile Lambert, Gustave Moonen, François Lallemend, Brigitte Malgrange, Saïda Hadjab

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Renaud VandenboschGroupe Interdisciplinaire de Génoprotéomique Appliquée-Neurosciences, Developmental Neurobiology Unit, University of Liège Liège, Belgium.
Eva ChocholovaGroupe Interdisciplinaire de Génoprotéomique Appliquée-Neurosciences, Developmental Neurobiology Unit, University of Liège Liège, Belgium.
Pierre A RobeDepartment of Human Genetics, University of Liège Liège, Belgium ; Groupe Interdisciplinaire de Génoprotéomique Appliquée-Research Center, University of Liège Liège, Belgium.
Yiqiao WangDepartment of Neuroscience, Karolinska Institute Stockholm, Sweden.
Cécile LambertBone and Cartilage Research Unit, Institute of Pathology, Centre Hospitalier Universitaire du Sart-Tilman Liège, Belgium.
Gustave MoonenGroupe Interdisciplinaire de Génoprotéomique Appliquée-Neurosciences, Developmental Neurobiology Unit, University of Liège Liège, Belgium ; Department of Neurology, Centre Hospitalier Universitaire du Sart Tilman Liège, Belgium.
François LallemendGroupe Interdisciplinaire de Génoprotéomique Appliquée-Neurosciences, Developmental Neurobiology Unit, University of Liège Liège, Belgium ; Department of Neuroscience, Karolinska Institute Stockholm, Sweden.
Brigitte MalgrangeGroupe Interdisciplinaire de Génoprotéomique Appliquée-Neurosciences, Developmental Neurobiology Unit, University of Liège Liège, Belgium.
Saïda HadjabGroupe Interdisciplinaire de Génoprotéomique Appliquée-Neurosciences, Developmental Neurobiology Unit, University of Liège Liège, Belgium ; Department of Neuroscience, Karolinska Institute Stockholm, Sweden.
University of Liège · BEKarolinska Institutet · SECentre Hospitalier Universitaire de Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurotrophins are key players of neural development by controlling cell death programs. However, the signaling pathways that mediate their selective responses in different populations of neurons remain unclear. In the mammalian cochlea, sensory neurons differentiate perinatally into type I and II populations both expressing TrkB and TrkC, which bind respectively brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT3). How these two neuronal populations respond differentially to these two neurotrophins remains unknown. Here, we report in rat the segregation of the nuclear factor-κB (NFκB) subunit p65 specifically within the type II population postnatally. Using dissociated cultures of embryonic and postnatal spiral ganglion neurons, we observed a specific requirement of NFκB for BDNF but not NT3-dependent neuronal survival during a particular postnatal time window that corresponds to a period of neuronal cell death and hair cell innervation refinement in the developing cochlea. Consistently, postnatal p65 knockout mice showed a specific decreased number in type II spiral ganglion neurons. Taken together, these results identify NFκB as a type II neuron-specific factor that participates in the selective survival effects of BDNF and NT3 signaling on developing spiral ganglion neurons.

Indexed as

cochleadevelopmentneuronal survivalneurotrophinsNF-κBspiral ganglion neurons

Identifiers

PMID24348336
PMCPMC3842586
OpenAlexW2055098985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.